Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue
Below are the drug manufacturers-other stocks on the NYSE in terms of revenue.
The trailing-twelve-month revenue at Teva Pharmaceutical Industries (NYSE: TEVA) is $20.54 billion. Teva's ROE for the same period is 11.36%.
The trailing-twelve-month revenue at Novo Nordisk A/S (NYSE: NVO) is $14.32 billion. Novo Nordisk's PEG ratio is 2.02.
The trailing-twelve-month revenue at Allergan (NYSE: AGN) is $6.74 billion. Allergan's EPS for the same period is $4.25.
The trailing-twelve-month revenue at Dr. Reddy's Laboratories (NYSE: RDY) is $2.25 billion. Dr. Reddy's operating margin for the same period is 19.87%.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Drug Manufacturers-Other Industry NYSE revenueTrading Ideas